NORTHWEST BIOTHERAPEUTICS INC (NWBO) Net margin 2016–2025
NORTHWEST BIOTHERAPEUTICS INC (NWBO) net profit margin by fiscal year — reported net income divided by reported revenue.
-4365.9%FY2025 · since FY2016: -12875.4% → -4365.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4365.9% | +1696.2 pp |
| FY2024 | -6062.1% | -2822.0 pp |
| FY2023 | -3240.1% | +3000.6 pp |
| FY2022 | -6240.8% | -24064.2 pp |
| FY2021 | 17823.5% | +58863.1 pp |
| FY2020 | -41039.6% | -40176.0 pp |
| FY2019 | -863.6% | +7824.3 pp |
| FY2018 | -8687.9% | +13080.9 pp |
| FY2017 | -21768.7% | -8893.3 pp |
| FY2016 | -12875.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice